Trial Profile
Randomized, crossover pharmacodynamic study comparing the effects of Zegerid (20 mg omeprazole/sodium bicarbonate) and Prilosec OTC [over the counter] (20 mg-equivalent omeprazole)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Omeprazole/sodium bicarbonate (Primary) ; Omeprazole; Sodium bicarbonate
- Indications Duodenal cancer; Erosive oesophagitis; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Gastrointestinal haemorrhage
- Focus Pharmacodynamics; Registrational
- Acronyms COMPLETED
- Sponsors Bayer; Schering-Plough
- 05 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Jun 2008 New trial record.